New York State Common Retirement Fund Satsuma Pharmaceuticals, Inc. Transaction History

New York State Common Retirement Fund

  • $73.9 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 02, 2021
SELL
$4.54 - $7.17 $286 - $451
-63 Closed
0 $0
Q2 2021

Aug 02, 2021
SELL
$4.8 - $7.25 $41,457 - $62,618
-8,637 Reduced 99.28%
63 $0
Q2 2020

Aug 07, 2020
BUY
$16.01 - $34.69 $51,232 - $111,008
3,200 Added 58.18%
8,700 $250,000
Q4 2019

Feb 05, 2020
BUY
$9.32 - $19.68 $51,260 - $108,240
5,500 New
5,500 $108,000

About Satsuma Pharmaceuticals, Inc.

STSA Quotes by TradingView
  • Ticker STSA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,587,500
  • Description
  • Satsuma Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, developing novel therapeutic products for the acute treatment of migraines. The company's lead product candidate is STS101, a drug-device combination of a proprietary dry-powder formulation of dihydroergotamine mesylate, which is in SUMMIT Phase 3 efficacy trials and can ...
More about STSA
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email